| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | TMDX Transmedics Group, Inc. | Basile Edward M64 | Director | Sell | 3,500 | $80.10 | $280,350.00 | -19.6% | -11.1% | +0.3% | |
| Mar 1, 2023 | ARAY Accuray Inc | Hoge Michael68 | Senior VP Global Operations | Sell | 11,977 | $2.89 | $34,613.53 | -2.3% | +25.8% | -9.4% | |
| Mar 1, 2023 | QTIH Qt Imaging Holdings, Inc. | Polar Asset Management Partners Inc.72 | 10% Owner | Sell | 154,600 | $10.40 | $1,607,840.00 | -10.6% | - | - | |
| Mar 1, 2023 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 30,000 | $22.48 | $674,487.00 | -6.8% | -5.9% | -86.1% | |
| Mar 1, 2023 | PETV Petvivo Holdings, Inc. | Jasper Joseph William | Director | Buy | 500 | $2.94 | $1,470.00 | +2.3% | - | - | |
| Mar 1, 2023 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 4,290 | $22.75 | $97,597.50 | -0.9% | +2.5% | -25.9% | |
| Mar 1, 2023 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 1,576 | $22.75 | $35,854.00 | -2.0% | +2.5% | -25.9% | |
| Mar 1, 2023 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 2,895 | $11.03 | $31,931.85 | -0.1% | +0.3% | -19.7% | |
| Mar 1, 2023 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $258.62 | $155,173.51 | -0.2% | +20.3% | -9.1% | |
| Mar 1, 2023 | BLFS Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | Sell | 844 | $22.75 | $19,201.00 | -1.4% | +2.5% | -25.9% | |
| Mar 1, 2023 | BSX Boston Scientific Corp | Monson Jonathan | SVP, Global Controller And CAO | Sell | 5,000 | $46.66 | $233,315.00 | -12.5% | +7.8% | +41.4% | |
| Mar 1, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 7,500 | $80.72 | $605,391.00 | -1.0% | -11.1% | +0.3% | |
| Mar 1, 2023 | IART Integra Lifesciences Holdings Corp | Davis Robert T. Jr. | EVP &President, Tt | Sell | 1,566 | $55.21 | $86,463.09 | -3.3% | -30.1% | -32.7% | |
| Mar 1, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 2,086 | $22.75 | $47,456.50 | -0.8% | +2.5% | -25.9% | |
| Mar 1, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 874 | $22.75 | $19,883.50 | -0.7% | +2.5% | -25.9% | |
| Mar 1, 2023 | INSP Inspire Medical Systems, Inc. | Ban Randy68 | Chief Commercial Officer | Sell | 10,000 | $8,353.11 | $83,531,091.44 | -33.4% | +11.2% | -32.1% | |
| Mar 1, 2023 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 1,203 | $22.75 | $27,368.25 | -1.0% | +2.5% | -25.9% | |
| Mar 1, 2023 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 1,264 | $11.03 | $13,941.92 | -1.4% | +0.3% | -19.7% | |
| Mar 1, 2023 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 710 | $259.48 | $184,230.80 | -5.9% | +20.3% | -9.1% | |
| Mar 1, 2023 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,206 | $11.03 | $13,302.18 | -0.3% | +0.3% | -19.7% | |
| Mar 1, 2023 | DXCM Dexcom Inc | Sayer Kevin R62 | President CEO And Chairman Of | Sell | 38,464 | $109.94 | $4,228,611.36 | -5.4% | +2.5% | +3.9% | |
| Mar 1, 2023 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 5,000 | $79.51 | $397,550.00 | -21.0% | -11.1% | +0.3% | |
| Mar 1, 2023 | LUNG Pulmonx Corp | Sung Derrick81 | Chief Financial Officer | Sell | 1,264 | $11.03 | $13,941.92 | -0.2% | +0.3% | -19.7% | |
| Mar 1, 2023 | PEN Penumbra Inc | Bose Arani57 | Director | Sell | 5,000 | $258.26 | $1,291,300.05 | -0.2% | +20.3% | -9.1% | |
| Mar 1, 2023 | OM Outset Medical, Inc. | Vazquez Martin84 | Chief Operating Officer | Sell | 5,000 | $22.33 | $111,650.50 | -4.6% | -5.9% | -86.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.